LifeStance Health Group Quarterly Cash Flow Statement
NASDAQ: LFSTHealth CareMedical/Nursing ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
LifeStance Health Group free cash flow
In the quarter ended Jun 30, 2026, LifeStance Health Group generated $99.9 million of operating cash flow and spent $12.0 million on capital expenditures. That left free cash flow of $87.9 million, a free-cash-flow margin of 20.2% of revenue. Free cash flow was up 55.2% from the prior year's $56.6 million.
LifeStance Health Group returned $48.5 million to shareholders through share repurchases, equal to 55% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
LifeStance Health Group cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 23.61M | 14.24M | 11.67M | 1.08M | -3.79M | 709.00K | -7.11M | -5.96M | -23.28M | -21.10M | -44.96M | -61.58M |
| Net Income growth (YoY) | — | +1908.89% | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 11.31M | 10.37M | 10.35M | 10.34M | 10.64M | 10.29M | 10.12M | 10.41M | 10.13M | 10.02M | 9.67M | 9.45M |
| Stock-Based Compensation | 19.75M | 15.20M | 16.70M | 18.30M | 21.12M | 18.58M | 16.15M | 14.89M | 24.55M | 20.58M | 20.92M | 21.52M |
| Change in Working Capital | 14.54M | 5.81M | -15.34M | 16.32M | 22.00K | -13.16M | 26.83M | 5.31M | 1.69M | -43.06M | 71.78M | -63.50M |
| Operating Cash Flow | 99.91M | 33.11M | 57.56M | 27.29M | 64.40M | -3.09M | 62.32M | 22.72M | 44.06M | -21.84M | 16.80M | -25.36M |
| Capital Expenditures | -11.99M | -10.77M | -10.91M | -10.29M | -7.75M | -7.17M | -6.30M | -5.05M | -5.11M | -5.10M | -11.41M | -9.80M |
| Investing Cash Flow | -17.89M | -13.91M | -10.91M | -10.29M | -7.75M | -7.17M | -6.30M | -5.05M | -5.11M | -5.10M | -11.41M | -9.80M |
| Share Repurchases | -48.52M | -49.11M | — | — | 0 | 0 | — | — | — | — | — | — |
| Debt Issued | — | — | — | — | — | — | 287.81M | 0 | — | — | 32.75M | 0 |
| Debt Repaid | -7.25M | 0 | -1.81M | -1.81M | -1.81M | -1.81M | -287.30M | -731.00K | -732.00K | -731.00K | -649.00K | -648.00K |
| Financing Cash Flow | -50.88M | -73.04M | -1.91M | -2.02M | -2.05M | -9.97M | -4.06M | -2.02M | -1.43M | -2.43M | 30.84M | -1.85M |
| Net Change in Cash | 31.15M | -53.84M | 44.74M | 14.97M | 54.59M | -20.23M | 51.96M | 15.65M | 37.52M | -29.37M | 36.22M | -37.00M |
| Free Cash Flow | 87.92M | 22.34M | 46.65M | 17.00M | 56.64M | -10.26M | 56.02M | 17.67M | 38.95M | -26.94M | 5.38M | -35.15M |
This table shows 12 quarterly periods of LifeStance Health Group's cash flow statement, from Q2 2026 back to Q3 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow LFST's reporting calendar. What is a cash flow statement?